Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.4M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
15M
-
Shares change
-
+15M
-
Total reported value, excl. options
-
$278M
-
Value change
-
+$278M
-
Number of buys
-
40
-
Price
-
$18.85
Significant Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q3 2021
40 filings reported holding OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK as of Q3 2021.
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15M shares
of 55.4M outstanding shares and own 27.04% of the company stock.
Largest 10 shareholders include FMR LLC (4.2M shares), HarbourVest Partners LLC (2.65M shares), Artal Group S.A. (2.27M shares), CHI Advisors LLC (1.06M shares), BlackRock Inc. (958K shares), SPHERA FUNDS MANAGEMENT LTD. (528K shares), PLATINUM INVESTMENT MANAGEMENT LTD (500K shares), Monashee Investment Management LLC (441K shares), Octagon Capital Advisors LP (370K shares), and VANGUARD GROUP INC (332K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.